Jabs DA, McCluskey P, Palestine AG, Thorne JE. The standardisation of uveitis nomenclature (SUN) project. Clin Exp Ophthalmol. 2022;9:991–1000.
Google Scholar
Tomkins-Netzer O, Talat L, Bar A, Lula A, Taylor SRJ, Joshi L, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. 2014;121:2387–92.
Google Scholar
de Smet MD, Taylor SRJ, Bodaghi B, Miserocchi E, Murray PI, Pleyer U, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011;30:452–70.
Google Scholar
Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844–8.
Google Scholar
García-Aparicio Á, García de Yébenes MJ, Otón T, Muñoz-Fernández S. Prevalence and Incidence of Uveitis: A Systematic Review and Meta-analysis. Ophthalmic Epidemiol. 2021;28:461–8.
Google Scholar
Rim TH, Kim SS, Ham DI, Yu SY, Chung EJ, Lee SC. Incidence and prevalence of uveitis in South Korea: a nationwide cohort study. Br J Ophthalmol. 2018;102:79–83.
Google Scholar
Acharya NR, Tham VM, Esterberg E, Borkar DS, Parker JV, Vinoya AC, et al. Incidence and prevalence of uveitis: results from the pacific ocular inflammation study. JAMA Ophthalmol. 2013;131:1405–12.
Google Scholar
Zhang Y, Amin S, Lung KI, Seabury S, Rao N, Toy BC. Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: A claims-based analysis. PloS one. 2020;15:e0237995.
Google Scholar
Miettinen R. Incidence of uveitis in Northern Finland. Acta Ophthalmol. 1977;55:252–60.
Google Scholar
Hwang D-K, Chou Y-J, Pu C-Y, Chou P. Epidemiology of uveitis among the Chinese population in Taiwan: a population-based study. Ophthalmology. 2012;119:2371–6.
Google Scholar
Kim ST, Seong SC 2016 national health insurance statistical yearbook. Health Insurance Review and Assessment Service, National Health Insurance service, 2017:622.
Kim BH, Chang IB, Lee S, Oh B-L, Hong IH. Incidence and prevalence of pediatric noninfectious uveitis in Korea: a population-based study. J Korean Med Sci. 2022;37. https://doi.org/10.3346/jkms.2022.37.e344.
Lerner A. 11th Annual Congress on immunology: the world incidence and prevalence of autoimmune diseases is increasing. J Timely Top Clin Immunol. 2018;2:42.
Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266.
Google Scholar
Glover K, Mishra D, Singh TRR. Epidemiology of ocular manifestations in autoimmune disease. Front Immunol. 2021;12:744396.
Google Scholar
Song YJ. The South Korean health care system. JMAJ. 2009;52:206–9.
OECD. Health at a Glance 2015. 2015.
Kang E, Yun J, Hwang S-H, Lee H, Lee JY. The impact of the COVID-19 pandemic in the healthcare utilization in Korea: Analysis of a nationwide survey. J Infect Public Health. 2022;15:915–21.
Google Scholar
Sim B, Nam EW. The Impact of COVID-19 pandemic on outpatient visits for all-cause and chronic diseases in Korea: a nationwide population-based study. Int J Environ Res Public Health. 2022;19:5674.
Google Scholar
Lee M, You M. Avoidance of Healthcare Utilization in South Korea during the Coronavirus Disease 2019 (COVID-19) Pandemic. Int J Environ Res Public Health. 2021;18:4363.
Google Scholar
Mantica G, Riccardi N, Terrone C, Gratarola A. Non-COVID-19 visits to emergency departments during the pandemic: the impact of fear. Public Health. 2020;183:40–41.
Google Scholar
Lee H, Park J. Changes in health care utilization during the MERS epidemic. Int J Infect Dis. 2018;73:187.
Tomer Y, Shoenfeld Y. Ageing and autoantibodies. Autoimmunity. 1988;1:141–9.
Google Scholar
Vadasz Z, Haj T, Kessel A, Toubi E. Age-related autoimmunity. BMC Med. 2013;11:94.
Google Scholar
Wang L, Wang F-S, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278:369–95.
Google Scholar
Do S-R. “Changes in healthcare utilization in South Korea”. Health Welf Issue Focus. 2009;8:1–8.
Gritz DC. Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491–500.
Google Scholar
Rathinam SR, Krishnadas R, Ramakrishnan R, Thulasiraj RD, Tielsch JM, Katz J, et al. Population-based prevalence of uveitis in Southern India. Br J Ophthalmol. 2011;95:463–7.
Google Scholar
González MM, Solano MM, Porco TC, Oldenburg CE, Acharya NR, Lin SC, et al. Epidemiology of uveitis in a US population-based study. J Ophthalmic Inflamm Infect. 2018;8:6.
Google Scholar
Miquel C-H, Faz-Lopez B, Guéry J-C. Influence of X chromosome in sex-biased autoimmune diseases. J Autoimmun. 2023:102992. https://doi.org/10.1016/j.jaut.2023.102992
Desai MK, Brinton RD. Autoimmune disease in women: endocrine transition and risk across the lifespan. Front Endocrinol. 2019;10:265.
Google Scholar
Cohen-Solal JF, Jeganathan V, Hill L, Kawabata D, Rodriguez-Pinto D, Grimaldi C, et al. Hormonal regulation of B-cell function and systemic lupus erythematosus. Lupus. 2008;17:528–32.
Google Scholar
Robert J, Alastair K, Benjamin R. Rheumatic Disease. In: Sadda S, Schachat A, Wilkinson C, editors. Ryan’s Retina. 7th ed. Amsterdam: Elsevier Health Sciences; 2022. p. 1684-712.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
Google Scholar
Alian SM, Khalil SS, Zaghlol RS. Charlson comorbidity index in patients with systemic lupus erythematosus in egypt and its relation with disease characteristics. Indian J Rheumatol. 2019;14:277–82.
Google Scholar
Dick AD, Tundia N, Sorg R, Zhao C, Chao J, Joshi A, et al. Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis. Ophthalmology. 2016;123:655–62.
Google Scholar
link